NKARTA INC. - COMMON STOCK
1.8000
10-三月-25 16:45:00
15 分钟延时
股票
-0.0400
-2.17%
今日范围
1.7500 - 1.8800
ISIN
N/A
来源
NASDAQ
-
Nkarta Reports Third Quarter 2021 Financial Results and Business Update
10 11月 2021 16:01:01 条件 Nasdaq GlobeNewswire
-
Nkarta to Participate at Upcoming Investor Conferences
04 11月 2021 08:04:00 条件 Nasdaq GlobeNewswire
-
Nkarta Announces Updates to NKX019 and NKX101 Clinical Development Programs
07 10月 2021 16:01:00 条件 Nasdaq GlobeNewswire
-
Nkarta to Present Preclinical Data from Engineered NK Cell Platform at SITC 36th Annual Meeting
01 10月 2021 08:08:00 条件 Nasdaq GlobeNewswire
-
Nkarta to Participate at Upcoming Investor Conference
14 9月 2021 08:32:00 条件 Nasdaq GlobeNewswire
-
Nkarta Reports Second Quarter 2021 Financial Results and Business Progress
12 8月 2021 16:02:00 条件 Nasdaq GlobeNewswire
-
Nkarta Establishes New Combined NK Cell Therapy Manufacturing Facility / Company Headquarters
14 7月 2021 07:00:00 条件 Nasdaq GlobeNewswire
-
Nkarta to Present at Upcoming Investor Conference
16 6月 2021 07:00:00 条件 Nasdaq GlobeNewswire
-
Nkarta Therapeutics CEO, Paul Hastings, Named BIO Chair for 2021-2022 Term
14 6月 2021 07:01:00 条件 Nasdaq GlobeNewswire
-
Nkarta Announces June 2021 Investor Conference Schedule
25 5月 2021 07:30:00 条件 Nasdaq GlobeNewswire
-
Nkarta Reports First Quarter 2021 Financial Results and Business Progress
13 5月 2021 16:02:00 条件 Nasdaq GlobeNewswire
-
28 4月 2021 08:02:00 条件 Nasdaq GlobeNewswire
-
Nkarta Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Business Progress
25 3月 2021 16:03:00 条件 Nasdaq GlobeNewswire
-
Nkarta Announces February and March 2021 Investor Conference Schedule
17 2月 2021 16:03:00 条件 Nasdaq GlobeNewswire